Reaching Your Goal Weight on Wegovy: What Comes Next

Step 1: Tell your prescriber before you change anything

The most common mistake at this point is stopping Wegovy unilaterally because the number on the scales looks right. Your prescriber needs to know you have reached your goal weight, because the next steps depend on your full picture: how long you have been on treatment, what dose you are on, how your weight-related conditions have responded, and what your maintenance plan looks like.

Wegovy is licensed in the UK for weight management alongside a reduced-calorie diet and increased physical activity, as set out in NICE's appraisal of semaglutide (TA875). That appraisal also recommends a maximum treatment duration of two years within a specialist weight management service, which means the timeline for any continuation or discontinuation is already part of the clinical framework. Your prescriber can explain where you sit within that.

If you are using Wegovy through nume's Wegovy service, every repeat order goes through a clinical re-review before anything is dispensed, that process is exactly the right moment to raise the question of what comes next.

Step 2: Understand what stopping semaglutide typically does to appetite and weight

Semaglutide does not leave a lasting metabolic reset. It works while it is present in the body, slowing gastric emptying and reducing appetite signals; once it clears, those effects fade. The clinical evidence on this is consistent. In the STEP 1 trial extension, participants who had lost roughly 15% of their body weight during 68 weeks of treatment regained most of it within a year of stopping, without structured support. You can read more about what typically happens to weight after stopping Wegovy and the factors that influence the outcome.

This is not a reason to stay on the medicine indefinitely, it is a reason to plan the transition properly. The return of appetite is a biological response, not a personal failing. Understanding it in advance makes it easier to respond constructively rather than be caught off guard when hunger patterns shift.

The NHS patient information on semaglutide is worth reading at this stage, particularly the sections on stopping treatment and managing expectations.

Step 3: Build the habits that carry weight maintenance forward

Medicines do the heavy lifting during active weight loss, but maintenance is where lifestyle infrastructure has to take over, or at least share the load. Practically, this means reviewing what your eating patterns look like now that appetite is suppressed, and planning what replaces that suppression when it reduces. Protein intake, fibre, hydration and regular resistance or strength activity are the pillars that tend to make the difference, and a dietitian can help you put numbers to them. If you want to understand when weight loss typically happens on Wegovy and how the pattern tends to unfold, that context is useful before you start planning what comes after. You will also find it useful to revisit practical guidance on getting the most from Wegovy during treatment, since those habits do not stop mattering at goal weight.

The timing of this review matters. Waiting until the day you stop your last pen is too late. Building new routines while Wegovy is still working (while appetite is still managed) gives them time to become automatic. Think of it like training for the next phase before the current one ends. One thing a prescriber hears fairly often is that people feel genuinely confident about maintenance until the medicine is gone, and then appetite hits harder than expected on a Tuesday afternoon, well after the transition plan was discussed. Doing the work ahead of that moment is the practical difference-maker.

Step 4: Decide, with your prescriber, between a taper, a pause or a structured stop

There is no single right answer here. Some people at goal weight continue at a lower maintenance dose; others plan a supervised stop with regular weight monitoring; others transition to a different clinical pathway. What is agreed depends on how your conditions have changed, what your weight trajectory looks like, and whether the NICE two-year limit applies to your situation.

If weight starts to rise during a period without medicine, that is clinical information rather than a failure. Many people also find it helpful to revisit how weight loss typically begins on Wegovy, since understanding the early pattern can give useful perspective on how the body responds once treatment ends. Understanding plateaus and weight shifts on Wegovy can help you recognise what is a normal fluctuation and what warrants a conversation with your prescriber. The treatment options at nume include a prescriber-led review at each stage, so the conversation can happen quickly when it needs to.

If you are weighing up longer-term private treatment options, the weight loss treatment overview sets out how different medicines compare and what is currently licensed in the UK, useful context before any decision about continuing or switching.